Cargando…

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease

Detalles Bibliográficos
Autores principales: Kang, Eun Ae, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289836/
https://www.ncbi.nlm.nih.gov/pubmed/35843685
http://dx.doi.org/10.5009/gnl220186
_version_ 1784748755504857088
author Kang, Eun Ae
Cheon, Jae Hee
author_facet Kang, Eun Ae
Cheon, Jae Hee
author_sort Kang, Eun Ae
collection PubMed
description
format Online
Article
Text
id pubmed-9289836
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-92898362022-07-18 Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease Kang, Eun Ae Cheon, Jae Hee Gut Liver Editorial Editorial Office of Gut and Liver 2022-07-15 2022-07-15 /pmc/articles/PMC9289836/ /pubmed/35843685 http://dx.doi.org/10.5009/gnl220186 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Kang, Eun Ae
Cheon, Jae Hee
Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
title Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
title_full Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
title_fullStr Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
title_full_unstemmed Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
title_short Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
title_sort antiviral prophylaxis against hepatitis b virus in patients treated with anti-tumor necrosis factor α agents for inflammatory bowel disease
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289836/
https://www.ncbi.nlm.nih.gov/pubmed/35843685
http://dx.doi.org/10.5009/gnl220186
work_keys_str_mv AT kangeunae antiviralprophylaxisagainsthepatitisbvirusinpatientstreatedwithantitumornecrosisfactoraagentsforinflammatoryboweldisease
AT cheonjaehee antiviralprophylaxisagainsthepatitisbvirusinpatientstreatedwithantitumornecrosisfactoraagentsforinflammatoryboweldisease